Platelet-covered nanocarriers for targeted delivery of hirudin to eliminate thrombotic complication in tumor therapy
Most patients are at high risk of thrombosis during cancer treatment. However, the major discrepancy in the therapeutic mechanisms and microenvironment between tumors and thrombosis makes it challenging for a panacea to treat cancer while being able to eliminate the risk of thrombosis. Herein, we de...
Saved in:
Main Authors: | Zhang, Kai, Ma, Zhaoyu, Li, Shuting, Zhang, Weiyun, Foda, Mohamed Frahat, Zhao, Yanli, Han, Heyou |
---|---|
Other Authors: | School of Chemistry, Chemical Engineering and Biotechnology |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/170511 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
SPHINGOLIPID INVENTORY AND VARIABILITY IN HUMAN PLATELETS
by: OH JEONGAH
Published: (2020) -
Growth factor releasing of platelet-rich fibrin and it's application in sinus augmentation
by: Narumol Pattaraporncharoen
Published: (2013) -
Studies of platelet abnormalities in thalassemia
by: Wittaya Tonsuwonnont
Published: (2023) -
Platelet aggregation and exogenous factors from animal sources
by: Manjunatha Kini, R.
Published: (2014) -
Stapled peptides as a new technology to investigate protein–protein interactions in human platelets
by: Iegre, Jessica, et al.
Published: (2018)